Masahiro Yoshimura

Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial

Johan Vansteenkiste, Byoung Chul Cho, Tõnu Vanakesa et al. · The Lancet Oncology · 2016 · 489 citations · Full text

Oncology, Immunology, Bronchial Neoplasm +8

Lewy bodies are ubiquitinated

Shigeki Kuzuhara, Hiroshi Mori, N. Izumiyama et al. · Acta Neuropathologica · 1988 · 412 citations

Gross Anatomy, Lewy Bodies, Body Image +4

Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease?

Kenji Kosaka, Masahiro Yoshimura, Ken‐ichi Ikeda et al. · PubMed · 1985 · 404 citations

Corticobasal Degeneration, Diffuse Type, Lewy Body Disease +17

Appropriate Sublobar Resection Choice for Ground Glass Opacity-Dominant Clinical Stage IA Lung Adenocarcinoma

Yasuhiro Tsutani, Yoshihiro Miyata, Haruhiko Nakayama et al. · CHEST Journal · 2013 · 310 citations

Surgical Oncology, Interventional Pulmonology, Medical Imaging +6

Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer

Toshihiko Satō, Satoshi Teramukai, Haruhiko Kondo et al. · Journal of Thoracic and Cardiovascular Surgery · 2013 · 308 citations · Full text

Acute Lung Injury, Inflammatory Lung Disease, Advanced Lung Disease +12